Health Trials

Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty

ConditionsSupra-Iliac Anterior Quadratus Lumborum BlockPericapsular Nerve Group BlockAnalgesiaTotal Hip Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorTanta University

About this trial

This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).

Eligibility criteria

Qualifiers

Age from 18 to 75 years.

Both sexes.

American Society of Anesthesiologists (ASA) classification I-III.

Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.

Disqualifiers

Known allergies to the drugs used.

Infection at the injection site.

Bleeding disorders.

Recognized neuromuscular disorders.

Trial design

Treatments tested in this trial

  • Supra-iliac anterior quadratus lumborum block
  • Pericapsular nerve group block

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tanta University

Lead sponsor

Source ClinicalTrials.gov